4/A//SEC Filing
McKhann Chas 4/A
Accession 0001251769-21-000107
CIK 0001251769other
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 8:55 PM ET
Size
9.7 KB
Accession
0001251769-21-000107
Insider Transaction Report
Form 4/AAmended
McKhann Chas
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2021-08-18$8.21/sh−21,156$173,691→ 686,122 total - Sale
Common Stock
2021-08-19$7.89/sh−21,148$166,858→ 664,974 total - Sale
Common Stock
2021-08-20$7.74/sh−21,148$163,686→ 643,826 total
Footnotes (4)
- [F1]On March 10, 2021, the holder was granted 707,278 performance-based restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 12, 2021. One-quarter (25%) of these RSUs vested upon the Company's achievement of at least $50 million of revenue for the trailing four quarters ended June 30, 2021. Amounts reported represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs.
- [F2]Represents weighted average price of shares sold. Prices ranged between $8.02 - $8.55, inclusive. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Represents weighted average price of shares sold. Prices ranged between $7.68 - $8.15, inclusive. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]Represents weighted average price of shares sold. Prices ranged between $7.59 - $8.09, inclusive. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Apollo Endosurgery, Inc.
CIK 0001251769
Entity typeother
Related Parties
1- filerCIK 0001631746
Filing Metadata
- Form type
- 4/A
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 8:55 PM ET
- Size
- 9.7 KB